Phase 3 pyoderma gangrenosum trial was halted after analysis of 30 patients showed no efficacy signal. InflaRx to prioritize INF904 with key data expected in chronic spontaneous urticaria and ...

Prof. Niels C. Riedemann, Chief Executive Officer and Founder of InflaRx, said: “We would like to thank the dedicated physicians and pyoderma gangrenosum patients for their participation in this ...

Pyoderma gangrenosum is an inflammatory condition that starts as a rapidly enlarging, very painful ulcer, usually due to a condition like Crohn's. It is thought to affect one in 100,000 in the UK ...

Orphan Drug Designation granted for treatment of pyoderma gangrenosum (PG) from US FDA and EMAProductive end-of-phase II meeting with FDA held for PG; dialogue ongoing related to Phase III program ...

Send comments and news tips to [email protected]. Cite this: Edited by Deepa Varma. Pyoderma Gangrenosum in Pregnancy Often Misdiagnosed - Medscape - July 11, 2025.

Our 36-year-old daughter-in-law is suffering from very painful pyoderma gangrenosum. Her latest outbreak followed a mosquito bite in September, and she is being treated as an outpatient. She also ...